BIOGEN INC. SEC Filings
BIIBLatest BIOGEN INC. (BIIB) SEC filings and EDGAR documents — 8-K current reports, 10-K/10-Q, Form 4 insider trades, with AI summaries.
Apple Q2 2026: Revenue +9% YoY, EPS $1.48 beat estimates
Biogen Q2 non-GAAP EPS $3.60, revenue up 3%, cuts FY guidance on deal charges
8-K current report
HAWKINS WILLIAM A bought 1,505 shares of Common Stock at $N/A on 2026-06-09
SHERWIN STEPHEN A bought 1,505 shares of Common Stock at $N/A on 2026-06-09
Rowinsky Eric K bought 1,505 shares of Common Stock at $N/A on 2026-06-09
Mantas Jesus B bought 1,505 shares of Common Stock at $N/A on 2026-06-09
LANGER SUSAN bought 1,505 shares of Common Stock at $N/A on 2026-06-09
Patolawala Monish D bought 1,505 shares of Common Stock at $N/A on 2026-06-09
Pangalos Menelas N bought 2,370 shares of Common Stock at $N/A on 2026-06-09; Pangalos Menelas N bought 1,505 shares of Common Stock at $N/A on 2026-06-09; Pangalos Menelas N sold 2,370 shares of Restricted Stock Unit at $N/A on 2026-06-09
Minor Lloyd bought 1,505 shares of Common Stock at $N/A on 2026-06-09
Freire Maria C bought 2,005 shares of Common Stock at $N/A on 2026-06-09
8-K current report
8-K/A current report
8-K current report
Keeney Adam bought 939 shares of Common Stock at $N/A on 2026-05-01; Keeney Adam sold 455 shares of Common Stock at $187.06 on 2026-05-01; Keeney Adam sold 939 shares of Restricted Stock Unit at $N/A on 2026-05-01
BIOGEN INC. filed 10-Q on 2026-04-29
8-K current report
8-K current report
Godbout Sean bought 181 shares of Common Stock at $N/A on 2026-04-01; Godbout Sean sold 54 shares of Common Stock at $183.78 on 2026-04-01; Godbout Sean sold 181 shares of Restricted Stock Unit at $N/A on 2026-04-01